ETF Holdings Breakdown of VERA

Stock NameVera Therapeutics Inc
TickerVERA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92337R1014

News associated with VERA

HC Wainwright Initiates Coverage on Vera Therapeutics (NASDAQ:VERA)
Investment analysts at HC Wainwright assumed coverage on shares of Vera Therapeutics (NASDAQ:VERA – Get Free Report) in a report issued on Monday, MarketBeat reports. The brokerage set a “buy” rating and a $75.00 price target on the stock. HC Wainwright’s target price would indicate a potential upside of 240.75% from the stock’s previous close. […] - 2025-05-07 05:22:48
Raymond James Financial Inc. Purchases Shares of 69,724 Vera Therapeutics, Inc. (NASDAQ:VERA)
Raymond James Financial Inc. acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 69,724 shares of the company’s stock, valued at approximately $2,948,000. Raymond James Financial Inc. owned approximately 0.11% of Vera Therapeutics […] - 2025-04-29 08:05:11
Renaissance Technologies LLC Takes $1.51 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA)
Renaissance Technologies LLC purchased a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 35,700 shares of the company’s stock, valued at approximately $1,510,000. Several other institutional investors and hedge funds […] - 2025-04-28 08:46:51
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Barclays PLC
Barclays PLC grew its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 16.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 99,148 shares of the company’s stock after buying an additional 13,753 shares during the period. Barclays PLC’s holdings in Vera Therapeutics were worth $4,192,000 as of its […] - 2025-04-28 07:59:04
Legal & General Group Plc Acquires 4,227 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)
Legal & General Group Plc boosted its holdings in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,809 shares of the company’s stock after purchasing an additional 4,227 shares during the period. […] - 2025-04-25 08:13:08
Investors Purchase Large Volume of Vera Therapeutics Call Options (NASDAQ:VERA)
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) was the target of some unusual options trading on Wednesday. Investors purchased 8,008 call options on the stock. This is an increase of approximately 2,661% compared to the average volume of 290 call options. Analyst Upgrades and Downgrades A number of brokerages have recently weighed in on […] - 2025-04-25 05:12:48
Geode Capital Management LLC Has $48.79 Million Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)
Geode Capital Management LLC boosted its position in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 14.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,153,325 shares of the company’s stock after purchasing an additional 148,660 shares during the period. Geode Capital Management LLC owned about 1.82% […] - 2025-04-15 08:00:50
Fmr LLC Increases Position in Vera Therapeutics, Inc. (NASDAQ:VERA)
Fmr LLC lifted its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 9.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,053,126 shares of the company’s stock after buying an additional 267,842 shares during the period. Fmr LLC owned approximately 4.82% […] - 2025-04-14 08:23:01
Vanguard Group Inc. Increases Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)
Vanguard Group Inc. grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 14.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,949,564 shares of the company’s stock after purchasing an additional 369,387 shares during the quarter. Vanguard Group Inc.’s holdings in Vera Therapeutics were worth $124,737,000 as of […] - 2025-04-09 07:42:53
American Century Companies Inc. Has $18.14 Million Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)
American Century Companies Inc. grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 11.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 428,940 shares of the company’s stock after acquiring an additional 42,526 shares during […] - 2025-04-01 09:10:47
Relative Strength Alert For Vera Therapeutics
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-03-25 16:24:58
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Victory Capital Management Inc.
Victory Capital Management Inc. boosted its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 515.0% in the fourth quarter, HoldingsChannel reports. The firm owned 235,267 shares of the company’s stock after buying an additional 197,014 shares during the period. Victory Capital Management Inc.’s holdings in Vera Therapeutics were worth $9,949,000 as […] - 2025-03-14 07:50:47
Vera Therapeutics (NASDAQ:VERA) Given New $71.00 Price Target at JPMorgan Chase & Co.
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price target decreased by JPMorgan Chase & Co. from $77.00 to $71.00 in a report released on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Other analysts have also recently issued research reports about the stock. The Goldman Sachs Group initiated […] - 2025-03-05 08:46:57
New York State Common Retirement Fund Boosts Position in Vera Therapeutics, Inc. (NASDAQ:VERA)
New York State Common Retirement Fund raised its stake in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 19.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 28,822 shares of the company’s stock after acquiring an additional 4,709 shares during the period. New York State Common Retirement Fund’s holdings in Vera Therapeutics were worth […] - 2025-03-03 08:43:01

VERA institutional holdings

The following institutional investment holdings of VERA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-09 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 26,943USD 584,933
2025-05-09 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 30,844 -0.3%USD 669,623 -1.8%
2025-05-09 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 30,785USD 668,342 -1.5%
2025-05-09 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 30,785USD 668,342 -1.5%
2025-05-09 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 781USD 16,956
Total =120,138 USD 2,608,196
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.